Yinghui Song

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Parthenolide inhibits the progression of intrahepatic cholangiocarcinoma by promoting ferroptosis through inhibiting UBD.

Parthenolide inhibits the progression of intrahepatic cholangiocarcinoma by promoting ferroptosis through inhibiting UBD.

Journal: Cancer biology & therapy

Published: April 29, 2026

Gamabufotalin impedes NSCLC progression by inhibiting the mitochondrial factor CHCHD2 and modulating XAF1 expression.

Gamabufotalin impedes NSCLC progression by inhibiting the mitochondrial factor CHCHD2 and modulating XAF1 expression.

Journal: Biochemical pharmacology

Published: January 06, 2026

RRM2 Promotes the Progression of Intrahepatic Cholangiocarcinoma by Inhibiting Ferroptosis Through the HIF-1α Pathway.

RRM2 Promotes the Progression of Intrahepatic Cholangiocarcinoma by Inhibiting Ferroptosis Through the HIF-1α Pathway.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 14, 2025

Resection combined with hyperthermic intraperitoneal chemotherapy in the treatment of spontaneously ruptured hepatocellular carcinoma: a multicenter retrospective study.

Resection combined with hyperthermic intraperitoneal chemotherapy in the treatment of spontaneously ruptured hepatocellular carcinoma: a multicenter retrospective study.

Journal: Therapeutic advances in medical oncology

Published: September 04, 2025

HBV-driven expansion of CXCR6+-exhausted T cells and CXCL16+ macrophage interaction: Implications for immunotherapy in HCC.

HBV-driven expansion of CXCR6+-exhausted T cells and CXCL16+ macrophage interaction: Implications for immunotherapy in HCC.

Journal: Innovation (Cambridge (Mass.))

Published: August 31, 2025

CGR11 promotes hepatocellular carcinoma progression by regulating autophagy through the PI3K/AKT pathway.

CGR11 promotes hepatocellular carcinoma progression by regulating autophagy through the PI3K/AKT pathway.

Journal: Frontiers in cell and developmental biology

Published: August 25, 2025

Next-generation sequencing elucidates the distinct mutational landscape of SMARCA4-deficient lung cancer.

Next-generation sequencing elucidates the distinct mutational landscape of SMARCA4-deficient lung cancer.

Journal: Oncology letters

Published: July 22, 2025

Drug repurposing: isosorbide mononitrate enhances tumor accumulation to augment sonodynamic therapy for hepatocellular carcinoma.

Drug repurposing: isosorbide mononitrate enhances tumor accumulation to augment sonodynamic therapy for hepatocellular carcinoma.

Journal: Journal of nanobiotechnology

Published: May 28, 2025

Research status of NIR-II fluorescent probe in liver cancer imaging.

Research status of NIR-II fluorescent probe in liver cancer imaging.

Journal: International journal of surgery (London, England)

Published: April 28, 2025

Research status of NIR-II fluorescent probe in liver cancer imaging.

Research status of NIR-II fluorescent probe in liver cancer imaging.

Journal: International journal of surgery (London, England)

Published: April 28, 2025

Postoperative adjuvant chemotherapy and chemoimmunotherapy after radical resection for biliary tract cancer: a retrospective study.

Postoperative adjuvant chemotherapy and chemoimmunotherapy after radical resection for biliary tract cancer: a retrospective study.

Journal: The oncologist

Published: April 10, 2025

Evaluation of genetic instability of short tandem repeats in hepatocellular carcinoma.

Evaluation of genetic instability of short tandem repeats in hepatocellular carcinoma.

Journal: Scientific reports

Published: March 26, 2025

Showing 1-12 of 54

Last Updated: 09/26/2026